Stocks
Globe Life Financial Statements (GL) |
||||||||||
| Globe Lifesmart-lab.ru | % | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 06.11.2023 | 31.12.2023 | 28.02.2024 | 31.03.2024 | 08.05.2024 | 08.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 1 384 | 1 416 | 1 416 | 1 416 | 1 416 | 5 664 | |||
| Operating Income, bln rub | 318.8 | 1 226 | 1 226 | 343.5 | 343.5 | 3 140 | ||||
| EBITDA, bln rub | ? | 318.8 | 0.000 | -26.6 | -28.6 | -28.6 | -83.8 | |||
| Net profit, bln rub | ? | 257.1 | 274.8 | 274.8 | 254.2 | 254.2 | 1 058 | |||
| OCF, bln rub | ? | 286.9 | 391.4 | 0.000 | 350.8 | 742.2 | ||||
| CAPEX, bln rub | ? | 10.8 | 13.1 | 0.000 | 9.11 | 22.2 | ||||
| FCF, bln rub | ? | 276.1 | 378.3 | 0.000 | 341.7 | 720.0 | ||||
| Dividend payout, bln rub | 21.4 | 21.2 | 0.000 | 21.1 | 42.3 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 8.31% | 0.00% | 7.70% | 0.00% | 8.31% | 4.00% | ||||
| OPEX, bln rub | 1 065 | 189.3 | 189.3 | 1 073 | 186.7 | 1 638 | ||||
| Cost of production, bln rub | 85.9 | 0.000 | 91.8 | 0.000 | 93.2 | 185.0 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 26.0 | 25.7 | 25.7 | 0.000 | 28.6 | 80.0 | ||||
| Assets, bln rub | 26 166 | 0.000 | 28 051 | 0.000 | 28 571 | 28 571 | ||||
| Net Assets, bln rub | ? | 4 623 | 0.000 | 4 487 | 4 487 | 5 039 | 5 039 | |||
| Debt, bln rub | 2 246 | 0.000 | 2 116 | 0.000 | 2 364 | 2 364 | ||||
| Cash, bln rub | 16 430 | 0.000 | 18 055 | 0.000 | 18 286 | 18 286 | ||||
| Net debt, bln rub | -14 183 | 0.00 | -15 939 | 0.00 | -15 923 | -15 923 | ||||
| Ordinary share price, rub | 108.7 | 121.7 | 121.7 | 116.4 | 116.4 | 115.9 | ||||
| Number of ordinary shares, mln | 94.6 | 95.5 | 94.1 | 95.2 | 93.9 | 93.9 | ||||
| Market cap, bln rub | 10 290 | 11 620 | 11 455 | 11 080 | 10 923 | 10 874 | ||||
| EV, bln rub | ? | -3 894 | 11 620 | -4 484 | 11 080 | -5 000 | -5 048 | |||
| Book value, bln rub | 3 660 | 0 | -2 004 | 4 487 | -1 574 | -1 574 | ||||
| EPS, rub | ? | 2.72 | 2.88 | 2.92 | 2.67 | 2.71 | 11.3 | |||
| FCF/share, rub | 2.92 | 0.00 | 4.02 | 0.00 | 3.64 | 7.67 | ||||
| BV/share, rub | 38.7 | 0.00 | -21.3 | 47.1 | -16.8 | -16.8 | ||||
| EBITDA margin, % | ? | 23.0% | 0.00% | -1.88% | -2.02% | -2.02% | -1.48% | |||
| Net margin, % | ? | 18.6% | 19.4% | 19.4% | 18.0% | 18.0% | 18.7% | |||
| FCF yield, % | ? | 13.8% | 9.08% | 12.5% | 8.70% | 12.0% | 6.62% | |||
| ROE, % | ? | 19.6% | 21.6% | 22.3% | 19.9% | 21.0% | ||||
| ROA, % | ? | 3.47% | 3.46% | 3.50% | 3.70% | |||||
| P/E | ? | 11.3 | 12.0 | 11.8 | 11.1 | 10.9 | 10.3 | |||
| P/FCF | 7.26 | 11.0 | 7.99 | 11.5 | 8.37 | 15.1 | ||||
| P/S | ? | 1.92 | 2.13 | 2.10 | 2.00 | 1.97 | 1.92 | |||
| P/BV | ? | 2.81 | -5.71 | 2.47 | -6.94 | -6.91 | ||||
| EV/EBITDA | ? | -3.34 | 13.2 | -5.24 | 21.0 | -9.47 | 60.2 | |||
| Debt/EBITDA | -12.2 | 0.00 | -18.6 | 0.00 | -30.2 | 190.0 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0 | ||||||
| CAPEX/Revenue, % | 0.78% | 0.00% | 0.93% | 0.00% | 0.64% | 0.39% | ||||
| Globe Life shareholders | ||||||||||
